Cooperative Agreement NU2GPS002909

This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...

The Department of State Bureau of African Affairs awarded a $119,943 cooperative agreement to Family Development Initiatives LIMITED of Zambia to support a Community Led Monitoring Initiative to Improve Quality of HIV Care Services in Eastern Province from January 19, 2023 through November 30, 2023. The initiative will support community-based monitoring of HIV care services delivered through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program in Eastern Province, Zambia....

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support the development of a novel universal rapid test for HIV diagnosis. IGE Immunodiagnostics & Therapeutics, LLC, a minority-owned small business, will receive $294,948 to adapt their existing HIV ELISA test into a 5th generation antigen/antibody combination rapid test format. The goal is to create a simple, rapid,...

Federal Cooperative Agreement Summary The Centers for Disease Control and Prevention (CDC), Center for Global Health, awarded $595,000 to the Ministerio De Salud (Ministry of Health) through the Global AIDS program (CFDA 93.067) on December 15, 2025, to support the implementation of high-impact HIV prevention, testing, and treatment models in Panama under the President's Emergency Plan for AIDS Relief (PEPFAR). The award, which extends through September 29, 2030, funds above-site technical...

The Department of State Bureau of African Affairs awarded a $110,000 project grant to Treatment Advocacy And Litera CY Campaign to implement the COMMUNITY LED MONITORING TO IMPROVE QUALITY OF HIV CARE IN ZAMBIA THROUGH CLIENT FEEDBACK project from March 1, 2022 to December 30, 2022. Under this award, Treatment Advocacy And Litera CY Campaign will work to improve HIV care quality in Zambia by establishing a community-led monitoring program that gathers client feedback. The grant is part of the...

Federal Project Grant Award Summary The John E. Fogarty International Center (FIC) awarded Partnership For Research And Action For Health $192,292 under the International Research and Research Training program (CFDA 93.989) to develop and pilot a digital health intervention addressing HIV prevention and testing among men who have sex with men (MSM) in Georgia. The project, spanning April 1, 2026 through March 31, 2029, will adapt evidence-based educational videos and digital content from prior...

PROTECT AL: PREP Optimization Through Enhanced Continuum Tracking The University of Alabama at Birmingham received a $2.59 million Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242), awarded September 18, 2025, with a completion date of May 31, 2030. The PROTECT AL initiative develops and deploys a data-driven dashboard system to optimize HIV pre-exposure prophylaxis (PrEP) utilization across seven Alabama Quality Management...

This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...

This federal Project Grant award of $709,872 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop and pilot test a couple-based intervention to address perinatal depression and improve adherence to prevention of mother-to-child transmission (PMTCT) of HIV in Malawi. The key objectives are to: 1) develop a couple-based intervention using problem-solving therapy and content on couple...